Health Catalyst, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Health Catalyst, Inc. on August 22, 2019. The filing serves to announce the Company's financial results for the second quarter of 2019. The Company is incorporated in Delaware and its common stock trades on The Nasdaq Global Select Market under the symbol HCAT.
Key Financial Metrics
The filing text itself does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the press release attached as Exhibit 99.1, which is incorporated by reference but not reproduced in the body of this 8-K document.
Material Changes
No specific material changes versus the prior comparable period are detailed in the text of this filing. The document solely references the issuance of the press release containing the comparative financial data.
Guidance, Outlook, and Risks
The filing does not contain management commentary, forward-looking guidance, risk factors, or details on contingencies and unusual items. Such information is presumed to be located in the referenced press release (Exhibit 99.1).
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated August 22, 2019) for specific Q2 2019 revenue and earnings figures.
- Verify year-over-year growth rates and margin trends in the attached press release.
- Check for any updated full-year 2019 guidance provided in the press release.
- Confirm the status of the Company's "Emerging Growth Company" election status as noted in the filing.